Morgan Stanley Call 145 NVO 16.01.2026
/ DE000ME2CPY9
Morgan Stanley Call 145 NVO 16.01.../ DE000ME2CPY9 /
| 13/09/2024 18:04:34 |
Chg.+0.10 |
Bid22:00:35 |
Ask22:00:35 |
Underlying |
Strike price |
Expiration date |
Option type |
| 1.83EUR |
+5.78% |
-
Bid Size: - |
-
Ask Size: - |
Novo Nordisk |
145.00 USD |
16/01/2026 |
Call |
Master data
| WKN: |
ME2CPY |
| Issuer: |
Morgan Stanley |
| Currency: |
EUR |
| Underlying: |
Novo Nordisk |
| Type: |
Warrant |
| Option type: |
Call |
| Strike price: |
145.00 USD |
| Maturity: |
16/01/2026 |
| Issue date: |
20/10/2023 |
| Last trading day: |
16/01/2026 |
| Ratio: |
10:1 |
| Exercise type: |
American |
| Quanto: |
No |
| Gearing: |
6.76 |
| Leverage: |
Yes |
Calculated values
| Fair value: |
1.48 |
| Intrinsic value: |
0.00 |
| Implied volatility: |
0.33 |
| Historic volatility: |
0.27 |
| Parity: |
-0.72 |
| Time value: |
1.83 |
| Break-even: |
149.21 |
| Moneyness: |
0.94 |
| Premium: |
0.21 |
| Premium p.a.: |
0.15 |
| Spread abs.: |
0.01 |
| Spread %: |
0.55% |
| Delta: |
0.57 |
| Theta: |
-0.02 |
| Omega: |
3.82 |
| Rho: |
0.69 |
Quote data
| Open: |
1.84 |
| High: |
1.84 |
| Low: |
1.83 |
| Previous Close: |
1.73 |
| Turnover: |
0.00 |
| Market phase: |
- |
All quotes in EUR
Performance
| 1 Week |
|
|
+19.61% |
| 1 Month |
|
|
-3.17% |
| 3 Months |
|
|
-26.51% |
| YTD |
|
|
+75.96% |
| 1 Year |
|
|
- |
| 3 Years |
|
|
- |
| 5 Years |
|
|
- |
| 10 Years |
|
|
- |
| 1W High / 1W Low: |
1.83 |
1.40 |
| 1M High / 1M Low: |
1.90 |
1.40 |
| 6M High / 6M Low: |
2.68 |
1.13 |
| High (YTD): |
25/06/2024 |
2.68 |
| Low (YTD): |
02/01/2024 |
0.99 |
| 52W High: |
- |
- |
| 52W Low: |
- |
- |
| Avg. price 1W: |
|
1.63 |
| Avg. volume 1W: |
|
360 |
| Avg. price 1M: |
|
1.74 |
| Avg. volume 1M: |
|
163.64 |
| Avg. price 6M: |
|
1.96 |
| Avg. volume 6M: |
|
43.24 |
| Avg. price 1Y: |
|
- |
| Avg. volume 1Y: |
|
- |
| Volatility 1M: |
|
101.01% |
| Volatility 6M: |
|
110.16% |
| Volatility 1Y: |
|
- |
| Volatility 3Y: |
|
- |
